Two Genen­tech vets re­unite at Im­mune-Onc to help steer its $33M dri­ve to the clin­ic

Look for yet an­oth­er play­er work­ing in the im­muno-on­col­o­gy space to en­ter the clin­ic with a nim­ble team of ex­pe­ri­enced ex­ecs fo­cused on dis­man­tling im­muno­sup­pres­sion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.